Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 27.70
-0.25 (-0.89%)
Sep 9, 2025, 1:35 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.15 billion as of September 9, 2025. Its market cap has decreased by -36.43% in one year.
Market Cap
2.15B
Enterprise Value
2.79B
Revenue
1.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
27.70
Market Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.15B, a decrease of -59.17%. That is a compound annual growth rate of -5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 2.15B | -18.23% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | 4.77B | 73.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 399.39B |
| PharmaEssentia | 172.96B |
| Bora Pharmaceuticals Co., LTD. | 93.08B |
| Lotus Pharmaceutical | 50.89B |
| Lumosa Therapeutics | 44.14B |
| Oneness Biotech | 37.16B |
| Polaris Group | 29.70B |
| Pell Bio-Med Technology | 28.71B |